Arcus Biosciences Overview
Arcus Biosciences Target Price
Analysts' 12-month price predictions for RCUS.
Get informed when a big investor buys or sells
+ FollowShare Price
$23.86
Average Target Price
$31.75
33.1% upside
33.1% upside4 analysts in the last 4 months
High: $47 | Low: $22
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2026-05-18 | Truist Financial | $35 | 46.7% upside |  |
| 2026-05-11 | Morgan Stanley | $22 |  7.8% downside | |
| 2026-04-20 | Leerink Partners | $47 | 97% upside | |
| 2026-02-12 | Wells Fargo | $23 | 3.6% downside | |
| 2026-01-12 | Goldman SachsRichard Law | $28 | 17.4% upside | |
| 2026-01-08 | Morgan Stanley | $20 | 16.2% downside | |
| 2025-12-12 | Truist Financial | $30 | 25.7% upside | |
| 2025-12-12 | H.C. Wainwright | $32 | 34.1% upside | |
| 2025-10-30 | Goldman SachsSalveen Richter | $16 | 32.9% downside | |
| 2025-10-29 | Wedbush | $35 | 46.7% upside | |
| 2025-10-29 | H.C. Wainwright | $28 | 17.4% upside | |
| 2025-10-07 | Truist FinancialAsthika Goonewardene | $39 | 63.5% upside | |
| 2025-05-07 | Wells FargoEva Fortea Verdejo | $26 | 9% upside | |
| 2024-10-24 | CitigroupYigal Nochomovitz | $46 | 92.8% upside | |
| 2024-10-21 | H.C. WainwrightEmily Bodnar | $20 | 16.2% downside | |
| 2024-10-08 | Wells FargoEva Fortea Verdejo | $29 | 21.5% upside | |
| 2024-10-08 | Morgan StanleyJudah Frommer | $35 | 46.7% upside | |
| 2024-08-09 | Bank of America SecuritiesJason Zemansky | $23 | 3.6% downside | |
| 2024-07-08 | BarclaysPeter Lawson | $25 | 4.8% upside | |
| 2024-06-24 | Truist FinancialAsthika Goonewardene | $44 | 84.4% upside | |
| 2024-06-04 | BarclaysPeter Lawson | $35 | 46.7% upside | |
| 2022-12-20 | Citigroup | $42 | 76% upside | |
| 2022-11-23 | Citigroup | $37 | 55.1% upside | |
| 2022-05-11 | WedbushRobert Driscoll | $42 | 76% upside | |